// App-Quantinova.ai

BS82 : Pyroptosis may not contribute to anthracycline doxorubicin and its metabolite doxorubicinol cytotoxicity in coronary artery endothelial cells

Researchers

Presenter

  • Handi Salim

Principal Investigators

  • Sean M Davidson

  • Derek M Yellon

Medical Centers

  • Hatter Cardiovascular Institute, UCL, Chenies Mews London, LND WCE HX United Kingdom, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Doxorubicin

  • Nigericin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved